PRESS RELEASE published on 04/08/2025 at 07:46, 1 year 7 months ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS GenSight Biologics met à disposition son Document d'Enregistrement Universel 2024 pour consultation en ligne Document D'Enregistrement Universel GenSight Biologics Thérapies Géniques Maladies Neurodégénératives Rétine
REGULATED PRESS RELEASE published on 04/08/2025 at 07:45, 1 year 7 months ago COGRA : RAPPORT FINANCIER SEMESTRIEL 2024/2025
REGULATED PRESS RELEASE published on 04/08/2025 at 07:45, 1 year 7 months ago COGRA : CHIFFRE D’AFFAIRES DU 3ème TRIMESTRE 2024/25 : 11,5 M€ Cogra annonce un chiffre d'affaires de 11,5 M€ au 3ème trimestre 2024/25, marquant un rebond de +49% avec la normalisation du marché. Perspectives de croissance rentable dans le secteur de l'énergie bois Chiffre D'affaires Croissance Cogra Énergie Bois Marché Normalisé
PRESS RELEASE published on 04/08/2025 at 07:43, 1 year 7 months ago INSIDE INFORMATION / OTHER NEWS RELEASES GenSight Biologics announces the filing of its 2024 Universal Registration Document with the French market authority, including financial reports and corporate governance details GenSight Biologics Gene Therapies Retinal Neurodegenerative Diseases 2024 Universal Registration Document Central Nervous System Disorders
PRESS RELEASE published on 04/08/2025 at 07:30, 1 year 7 months ago Informations privilégiées / Autres communiqués Fill Up Média obtient le label 'DOOH Trust' de l'ACPM, garantissant transparence et fiabilité des campagnes publicitaires. La régie renforce son offre avec cette certification Certification Fill Up Media Campagnes Publicitaires DOOH Trust ACPM
PRESS RELEASE published on 04/08/2025 at 07:30, 1 year 7 months ago Inside Information / Other news releases MaaT Pharma announces positive safety interim analysis from DSMB for Phase 2b trial evaluating MaaT033 for patients receiving Allo-HSCT, demonstrating favorable safety profile and tolerability Phase 2B Trial MaaT Pharma Safety Analysis MaaT033 Allo-HSCT
PRESS RELEASE published on 04/08/2025 at 07:30, 1 year 7 months ago Informations privilégiées / Autres communiqués MaaT Pharma annonce résultat positif analyse intermédiaire sécurité essai clinique Phase 2b MaaT033 allo-GCSH. DSMB recommande poursuite essai sans modification Sécurité DSMB MaaT Pharma Analyse Intermédiaire Allo-GCSH
PRESS RELEASE published on 04/08/2025 at 07:00, 1 year 7 months ago BIOVERSYS TO PRESENT BV100 PHASE 2 DATA AT 35TH ESCMID GLOBAL 2025 BioVersys to present BV100 Phase 2 data at 35th ESCMID Global 2025. Oral presentation on positive VABP trial read-out & poster presentations on Acinetobacter baumannii & NTM data Clinical Data BV100 Antibacterial Products BioVersys ESCMID Global 2025
PRESS RELEASE published on 04/08/2025 at 07:00, 1 year 7 months ago Nyxoah Provides Update on FDA Approvable Letter for Genio System Nyxoah provides update on FDA Approvable Letter for Genio System, expecting full PMA approval in Q2 2025 after addressing final requirements FDA Nyxoah Genio System Approvable Letter PMA Approval
PRESS RELEASE published on 04/08/2025 at 07:00, 1 year 7 months ago Shuttle traffic in March 2025 Getlink reports increased truck shuttle traffic and decreased passenger shuttle traffic in March 2025. Detailed statistics and future traffic figures shared Traffic Figures Getlink Channel Tunnel Truck Shuttle Passenger Shuttle
Published on 11/20/2026 at 15:00, 2 days 1 hour ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 2 days 2 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 2 days 2 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 2 days 3 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 2 days 3 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 1 day 17 hours ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 1 day 18 hours ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 1 day 19 hours ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 1 day 20 hours ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 1 day 22 hours ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 1 day 22 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 1 day 23 hours ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 1 day 23 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 2 days 21 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR